Clinical Trials Directory

Trials / Completed

CompletedNCT03394378

The Impact of Non-Alcoholic Fatty Pancreas Disease on Outcome of Acute Pancreatitis

Status
Completed
Phase
Study type
Observational
Enrollment
1,662 (actual)
Sponsor
Ningbo No. 1 Hospital · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers

Summary

Obesity is a well-established risk factor for acute pancreatitis (AP). As for non-alcoholic fatty pancreas disease (NAFPD), it is evident that it is correlated with obesity. This is apparently the first study evaluating the association between NAFPD and severity of AP after taking into account several covariates.

Detailed description

Acute pancreatitis (AP) is a common disease with a highly variable clinical course, which can range from a mild, self-limited disease to severe disease with a mortality rate of 10-20%. It is vital to distinguish severe cases early because they require more aggressive fluid resuscitation and early nutritional support. Obesity is a well-established risk factor for acute pancreatitis (AP). It leads to ectopic fat accumulation in visceral organs, such as the liver, skeletal muscles, heart and pancreas. Assuming that attenuation in the pancreas seen on unenhanced computed tomography (CT) scanning is inversely associated with severe outcomes in AP, we investigated the relationship between NAFPD and severity of AP and the significance of pancreas attenuation for the prognosis and mortality in AP patients. The result of this study suggest that decreased pancreas attenuation and P/S ratio are strong predictors of severe pancreatitis, mortality, systemic complication.

Conditions

Timeline

Start date
2017-11-06
Primary completion
2017-12-03
Completion
2017-12-15
First posted
2018-01-09
Last updated
2018-01-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03394378. Inclusion in this directory is not an endorsement.